Syndax Pharmaceuticals Statistics
NASDAQ: SNDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.72-0.41 (-4.49%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Syndax Pharmaceuticals by the numbers
Syndax Pharmaceuticals has a market capitalization of $785.0 million based on 90.03M shares outstanding. With trailing EPS of $-2.37, Syndax Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.7% below its 50-day average and 55.1% below its 200-day average.
Average daily trading volume is 2.63M shares, or about $22.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SNDX valuation vs. peer median
| Metric | SNDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $785.05M | $773.14M | +2% |
| Avg. volume | 2.63M | 1.32M | +99% |
Peer median across 8 companies: IRWD, VSTM, COLL, ORIC, RIGL, CRVS, PHAR, ARDX.
Valuation
- Market cap
- $785.05M
- Price / sales (latest FY)
- 4.55
- EPS (TTM)
- $-2.37
- Shares outstanding
- 90.03M
Price and trading
- Previous close
- 9.13
- Open
- 9.14
- Day range
- 8.69 – 9.27
- 52-week range
- 8.41 – 25.59
- 52-week change
- -50.00%
- Beta
- —
- Volume
- 2.18M
- Average volume
- 2.63M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 785.05M
- Forward Pe
- -11.14
- Eps
- -2.37
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.59
- Week52 Low
- 8.41
- Avg Volume
- 2.63M
- Shares Outstanding
- 90.03M
- Ma50
- 14.22
- Ma200
- 19.43
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -65.92%
- Pct From52w Low
- 3.69%